2 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Methylmalonic Acidemia (MMA): new trials by email Literature Review of Methylmalonic Acidemia (MMA) trials Research Report on Methylmalonic Acidemia (MMA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA SEL-302 - Methylmalonic Acidemia (MMA) | Phase 1 / Phase 2 | Withdrawn | Selecta Biosciences, Inc. | 2022-12-19 | 2024-09-24 | |
| Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia mRNA-3704 - Methylmalonic Acidemia (MMA), Metabolism, Inborn Errors | Phase 1 / Phase 2 | Withdrawn | ModernaTX, Inc. | 2019-05-28 | 2020-11-13 |
Methylmalonic acidemia (2) · Metabolism, Inborn Errors (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
ModernaTX, Inc. (1) · Selecta Biosciences, Inc. (1)
United States (1)